The table below shows 4D Molecular Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$3.05M
$90.00K
$15.00K
$14.00K
$3.00K
$5.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
FDMT annual revenue (10-K history)
4D Molecular Therapeutics, Inc. reported annual revenue of $85.21M for fiscal year 2025. That is up 230194.6% from $37.00K in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $6.99M (FY 2019) to $85.21M. Figures come from the company's audited annual reports as filed with the SEC.